This could be a significant step forward in computation. Years ago I read an article on what was required by…
Athenahealth Acquires RazorInsights
Athenahealth announced this morning that it has acquired inpatient EHR vendor RazorInsights, which primarily serves rural, critical access, and small community hospitals. Terms were not disclosed, but an HIStalk reader who tipped me off early to the announcement says the acquisition price was $40 million.
Athenahealth says it will “leverage RazorInsights’ inpatient expertise and award-winning technology to extend its presence into the 50-bed-and-under inpatient care environment, which accounts for approximately one-third of the US hospital market.”
The announcement cites the RazorInsights customer base of 25 hospitals, the success of some of its customers in attesting for Meaningful Use Stage 2, and its cloud-based delivery model.
Athenahealth Chairman and CEO Jonathan Bush said in the announcement, “Today’s hospital market is woefully underserved when it comes to IT systems and IT partners that are accountable for reducing costs, increasing quality, and enabling a better patient experience. With RazorInsights, athenahealth will immediately be injected into the inpatient care environment; this is a natural extension for our cloud-based services, will tremendously grow our network knowledge, and will accelerate our introduction of results-oriented, inpatient solutions that hospitals can confidently invest in and demand accountability from.”
The fact that no one commented speaks volumes. I’m shorting Athena down to 20 dollars by Q3 2016.
Ha… was going to look at the one comment and then say what you said. Very telling in my opinion as well.
I think ATHN needs to do everything right to continue to justify their current ‘darling’ status. After that, they join the rest of the crowd in their sector, multiple wise. Clearly they have a clue. The question is is that enough to grab market share and, more importantly, new and different revenue streams that already are not becoming commoditized… Einhorn has an interesting thesis. Puts his money where his mouth is at least… near term (’15) could be wild ride. The massive short position could lead to successive squeezes on any ‘revolutionary’ news. That alone makes me hesitant to short this baby.